On Friday, Following Stocks were among the “Top 100 Gainers” of U.S. Stock Market: Intel Corporation (NASDAQ:INTC), Skyworks Solutions Inc. (NASDAQ:SWKS), Carnival Corporation (NYSE:CCL), Juno Therapeutics Inc. (NASDAQ:JUNO)

Intel Corporation (NASDAQ:INTC), with shares gained 6.38%, closed at $32.

Skyworks Solutions Inc. (NASDAQ:SWKS), with shares jumped 6.22%, settled at $98.83.

Carnival Corporation (NYSE:CCL), with shares climbed 6.08%, and closed at $47.12, hitting new 52-week high of $47.70.

Juno Therapeutics Inc. (NASDAQ:JUNO), surged 5.93%, and closed at $56.60.

Latest NEWS regarding these Stocks are depicted underneath:

Intel Corporation (NASDAQ:INTC)

Micron Technology, Inc. (NASDAQ:MU), and Intel Corporation (INTC), revealed the availability of their 3D NAND technology, the world’s highest-density flash memory. Flash is the storage technology used inside the lightest laptops, fastest data centers, and nearly every cellphone, tablet and mobile device.

This new 3D NAND technology, which was jointly developed by Intel and Micron, stacks layers of data storage cells vertically with extraordinary precision to create storage devices with three times higher capacity than competing NAND technologies. This enables more storage in a smaller space, bringing noteworthy cost savings, low power usage and high performance to a range of mobile consumer devices in addition to the most demanding enterprise deployments.

Planar NAND flash memory is nearing its practical scaling limits, posing noteworthy challenges for the memory industry. 3D NAND technology is poised to make a dramatic influence by keeping flash storage solutions aligned with Moore’s Law, the trajectory for continued performance gains and cost savings, driving more widespread use of flash storage.

Intel Corporation designs, manufactures, and sells integrated digital technology platforms worldwide. It operates through PC Client Group, Data Center Group, Internet of Things Group, Mobile and Communications Group, Software and Services, and All Other segments.

Skyworks Solutions Inc. (NASDAQ:SWKS)

S&P MidCap 400 constituent Skyworks Solutions Inc. (SWKS) replaced PetSmart Inc. (PETM) in the S&P 500, S&P SmallCap 600 constituent Maximus Inc. (MMS) replaced Skyworks Solutions in the S&P MidCap 400, and Republic Airways Holdings Inc. (RJET) replaced Maximus in the S&P SmallCap 600 after the close of trading on Wednesday, March 11.

Skyworks Solutions, Inc., together with its auxiliaries, designs, develops, manufactures, and markets analog and mixed signal semiconductors worldwide.

Carnival Corporation (NYSE:CCL)

Carnival Corporation (CCL), declared non-GAAP net revenue of $159 million, or $0.20 diluted EPS, for the first quarter of 2015 contrast to non-GAAP net loss for the first quarter of 2014 of $3 million, or $0.00 per share. For the first quarter of 2015, U.S. GAAP net revenue, which comprised of unrealized losses on fuel derivatives of $112 million, was $49 million, or $0.06 diluted earnings per share. For the first quarter of 2014, U.S. GAAP net loss was $20 million, or $0.03 diluted loss per share. Proceeds for the first quarter of 2015 were $3.5 billion contrast to $3.6 billion in the preceding year.

Key metrics for the first quarter 2015 contrast to first quarter 2014 were as follows:

• On a constant dollar basis, net proceed yields (net proceed per accessible lower berth day or “ALBD”) raised 2.0 percent for 1Q 2015, which was better than the corporation’s December guidance of flat to up 1 percent. Gross proceed yields reduced 3.1 percent in current dollars due to changes in currency exchange rates.
• Net cruise costs not including fuel per ALBD raised 2.4 percent in constant dollars primarily due to higher dry-dock costs and advertising expenses. Costs were lower than December guidance, up 5.5 to 6.5 percent, substantially all due to the timing of expenses between quarters. Gross cruise costs counting fuel per ALBD in current dollars declined 9.6 percent due to changes in fuel prices and currency exchange rates.
• Fuel prices declined 38 percent to $406 per metric ton for 1Q 2015 from $654 per metric ton in 1Q 2014.
• Fuel consumption per ALBD reduced 3.7 percent in 1Q 2015 contrast to the preceding year.
• Changes in currency exchange rates reduced earnings by $0.06 per share (constant currency).

Carnival Corporation operates as a cruise corporation worldwide. It provides vacations to various cruise destinations. The corporation offers cruise services under the Carnival Cruise Lines, Holland America Line, Princess Cruises, and Seabourn brand names in North America; and AIDA Cruises, Costa Cruises, Cunard, and P&O Cruises names in Europe, Australia, and Asia.

Juno Therapeutics Inc. (NASDAQ:JUNO)

Formerly on March 18, Juno Therapeutics Inc. (JUNO), stated Cash burn of $89.2 million in 2014 comprised primarily of cash used in operations of $82.5 million, investment in the preferred stock of a planned supplier of $3.5 million, and purchases of property and equipment of $2.9 million.

Research and development expenses, inclusive of non-cash expenses, computed in accordance with GAAP, were $182.1 million for the fourth quarter of 2014 and $204.5 million for the year ended December 31, 2014. Comprised of in R&D costs are expenses related to the change in estimated value and accrual period for Juno’s potential success payments to the Fred Hutchinson Cancer Research Center (FHCRC) and Memorial Sloan Kettering Cancer Center (MSK), upfront cash and stock payments to attain technology related to JCAR018, and costs to expand Juno’s overall research and development capabilities and advance programs at Juno’s founding institutions.

General and administrative expenses, inclusive of non-cash expenses, computed in accordance with GAAP, were $6.1 million for the fourth quarter of 2014 and $19.5 million for the year ended December 31, 2014, comprising of personnel costs, counting non-cash stock-based compensation expense, and patent and corporate legal fees.

Net loss attributable to ordinary stockholders for the fourth quarter of 2014 was $191.9 million, or $13.68 per share. Net loss attributable to ordinary stockholders for the year ended December 31, 2014 was $310.9 million, or $36.82 per share.

Juno Therapeutics, Inc., a biopharmaceutical corporation, engages in developing cell-based cancer immunotherapies. The corporation develops cell-based cancer immunotherapies based on its chimeric antigen receptor and T cell receptor technologies to genetically engineer T cells to recognize and kill cancer cells.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.